Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ACRS Aclaris Therapeutics Inc

2,55

0,05 (2,00%)

18 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Aclaris Therapeutics Charts.

Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Aclaris Therapeutics Charts.

News Aclaris Therapeutics Inc

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Montag 6 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 4 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Donnerstag 2 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 31 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Donnerstag 19 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 12 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 6 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 3 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Dienstag 3 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Aclaris Therapeutics Inc News-Artikel

Energy Select Sector SPDR

Euro vs Sterling

BNP Paribas (QX)

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen